期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 35, 期 4, 页码 168-177出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2014.02.001
关键词
target identification; translational medicine; multiple-component and multiple-target drugs; gut microbiota; remote target
资金
- National Natural Science Foundation of China [81325025, 91029746, 81273586]
- Natural Science Foundation of Jiangsu province [BK2012026]
- Jiangsu Province Key Laboratory of Drug Metabolism and Pharmacokinetics Projects [BM2012012]
Natural medicines (NMs) are indispensable sources for the development of modern drugs. However, the targets for most natural compounds are unknown and the current pharmacokinetic evaluation systems developed for target-defined drugs may not be directly applicable to NM-based drug discovery, which is a major hindrance in bringing natural compounds to the clinic. Here, we propose the concept of 'reverse pharmacokinetics' and discuss how a 'reverse pharmacokinetics' perspective could help clarify key questions in modern drug discovery from NMs with validated clinical benefits, thereby strengthening the translational potential. Reverse pharmacokinetics can provide physiologically relevant clues to the target identification and mechanistic study of NMs, which may also innovate drug discovery for complex diseases. We anticipate that an evolving deep understanding of the novel mode of action of natural compounds with a reverse pharmacokinetic insight may improve discovery of both single ingredient and multiple-component modern drugs from NMs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据